MedTrace Logo

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)

NCT04073433 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2024-10-31

No results posted yet for this study

Summary

The goal of this clinical trial is to study MDMA-assisted therapy in healthy volunteers and provide training of therapists. The main question it aims to answer is:

Does MDMA-assisted therapy result in personal and professional benefits?

Participants will have a non-drug preparatory session prior to each experimental session and an integrative session after each experimental session.

Conditions

  • Psychological Effects of Study Drug

Interventions

DRUG

Midomafetamine HCl

120 mg midomafetamine HCl

BEHAVIORAL

Therapy

Non-directive therapy conducted during MDMA-assisted therapy session

Sponsors & Collaborators

Principal Investigators

  • Marcela Ot'alora · Private Practice

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04073433 on ClinicalTrials.gov